Skip to content
Search

Latest Stories

LloydsPharmacy apologises for emergency contraception refusal in south London branch

The Guardian newspaper reports that LlodysPharmacy has been forced to apologise after a customer was refused emergency contraception by a ‘relief’ pharmacist.

The incident happened last week (Sept 30) at a south London branch of the multiple.


The patient was quoted as saying that she felt “upset and humiliated” when the pharmacist told her she was unable to distribute the contraception “for religious reasons.”

A spokesperson for LloydsPharmacy confirmed the incident to Pharmacy Business: "We are extremely saddened to confirm that a patient was refused contraception on the basis of one of our relief pharmacist's religious beliefs."

Apologising for "any distress this has caused the patient", the company said it "would like to offer our full support with providing any further help needed by this individual."

“We support women’s choice and provide numerous contraceptive and sexual health services every day from our community pharmacies,” the spokesperson said. “We wholly respect pharmacists’ beliefs but expect them to follow the guidelines from the regulator [GPhC] with responsibility for the profession.”

According to General Pharmaceutical Council guidance, pharmacists should “recognise their own values and beliefs but… not impose them on other people”. They are also obliged to “take responsibility for ensuring that person-centred care is not compromised because of their personal values and beliefs”.

Last year, a customer was denied pre-ordered emergency contraception at another branch of the multiple in Brighton. The pharmacist there told the patient that the product was ready but would not be distributed for “personal reasons”.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less